Researchers Presented Results From Two Studies That Tested Combination Of REP2139 And Pegylated Interferon In Patients With Hepatitis B And Hepatitis D
December 27, 2019
Healio (12/26, Bennett) reports researchers presented the results of the REP 301 and REP 401 studies at HEP DART 2019 indicate that “combination therapy with REP2139 and pegylated interferon led to high rates of hepatitis B seroconversion in patients coin...